跳到主要导航 跳到搜索 跳到主要内容

Clinical evaluation of early marker in diagnosing rheumatoid arthritis

  • Cheng Pengfei
  • , Liu Yuanrui
  • , Chen Shu

科研成果: 期刊稿件 › 论文 › 同行评审

4 引用 (Scopus)

摘要

Objective: To evaluate the clinic diagnostic value of the assay of rheumatoid factor (RF), anti-RA33, anti-keratin antibody (AKA), anti-pernuclear factor (APF) and anti-cyclic citrullinated peptide antibody (anti-CCP) in serum of patients with rheumatoid arthritis (RA). Methods: RF was measured by the rate scatting immunity method, anti-CCP and anti-RA33 were measured by ELISA, AKA and APF were measured by immunity fluorescence method in 68 patients with RA and in 98 patients without RA and in 40 normal controls. Results: The sensitivity of RF, anti-RA33, AKA, APF and anti-CCP was 76.47%, 33.82%, 35.29%, 39.71% and 80.88%, respectively; the specificity was 91.84%, 92.86%, 97.96% and 98.98%, 98.98%, respectively; positive predictive value was 86.67, 76.67, 92.31, 96.43 and 98.21 respectively; usable degree was 69.04%, 39.78%, 47.27%, 50.85% and 80.79%, respectively in RA patients; anti-CCP had no statistical difference with RF(P>0.05), but it had a statistical difference with anti-RA33, AKA and APF(P<0.01) in the diagnosis. Conclusion: The combined detection of anti-CCP and RF presents good sensitivity and specificity in diagnosing RA at the early stage.
投稿的翻译标题Clinical evaluation of early marker in diagnosing rheumatoid arthritis
源语言中文
页(从-至)529-532
页数4
期刊Medical Journal of Wuhan University
卷26
期4
出版状态已出版 - 1月 2005

关键词

  • biological marker
  • cyclic citrullinated peptide antibody
  • keratin antibody
  • pernuclear factor antibody
  • rheumatoid factor
  • unclassified drug
  • article
  • controlled study
  • enzyme linked immunosorbent assay
  • human
  • immunofluorescence test
  • major clinical study
  • rheumatoid arthritis
  • sensitivity and specificity
  • statistical analysis

收录

  • Scopus

学术指纹

探究 'Clinical evaluation of early marker in diagnosing rheumatoid arthritis' 的科研主题。它们共同构成独一无二的学术指纹。

引用此